Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2008
12/30/2008CA2348413C Detection of human papilloma virus in papanicolaou (pap) smears
12/30/2008CA2313380C Method for creating polynucleotide and polypeptide sequences
12/30/2008CA2247545C Method of isolation of primer extension products with modular oligonucleotides
12/30/2008CA2246259C Genetic markers and methods for the detection of escherichia coli serotype-0157:h7
12/30/2008CA2244891C Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
12/30/2008CA2229558C Mono-allelic mutation analysis for identifying germline mutations
12/30/2008CA2219807C Systematic evolution of ligands by exponential enrichment: tissue selex
12/30/2008CA2218929C Compositions in glassy phase, stabilised by a sugar
12/30/2008CA2134863C Aspergillus niger aspartic protease
12/30/2008CA2132349C Chimeric receptor genes and cells transformed therewith
12/30/2008CA2117612C Periplasmic membrane-bound system for detecting protein-protein interactions
12/30/2008CA2113744C Methods for regulating the immune response using ctla4-binding molecules and il4-binding molecules
12/25/2008US20080320617 Compositions and methods for genetic modification of plants
12/25/2008US20080320613 Modulating myo-inositol catabolism in plants
12/25/2008US20080320612 Vascular-preferred promoter sequences and uses thereof
12/25/2008US20080320610 Transgenic fish with increased unsaturated fatty acid content
12/25/2008US20080320609 Diabetes Model Animal
12/25/2008US20080320388 Gene information display method and apparatus
12/25/2008US20080319711 Effective factor extraction system and its method and program
12/25/2008US20080319179 A nucleotide having a base attached to a detectable label through a cleavable linker; has a deoxyribose comprising a cleavable chemical group capping the 3' OH group of the deoxyribose and wherein both the cleavable linker and the capping cleavable chemical group are cleavable by light
12/25/2008US20080319178 Chimera humanized vascular endothelial growth factor
12/25/2008US20080319174 Chimera humanized vascular endothelial growth factor
12/25/2008US20080319173 Blood group antigen fusion polypeptides and methods of use thereof
12/25/2008US20080319167 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
12/25/2008US20080319165 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least one neuropeptide
12/25/2008US20080318896 Useful in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing; enhancing silencing of a target mRNA
12/25/2008US20080318895 Intranasal delivery of nucleic acid molecules
12/25/2008US20080318894 Rna antagonist compounds for the modulation of her3
12/25/2008US20080318891 Antisense oligonucleotides against thymidylate synthase
12/25/2008US20080318885 Method for Modulating Responsiveness to Steroids
12/25/2008US20080318868 Use of Mycobacterial Mannosylated Lipoglycans Peptide Mimotopes For Treating Inflammation
12/25/2008US20080318867 Virulent Phages to Control Listeria Monocytogenes in Foodstuffs and in Food Processing Plants
12/25/2008US20080318860 High Activity Growth Factor Mutants
12/25/2008US20080318856 administering a monomer protein comprising an amino acid sequence belonging to the TGF- beta super family, wherein alanine at position 83 is replaced with a serine, threonine or valine; protein induces differentiation of osteoblasts measured by promoting alkaline phosphatase activity to a patient
12/25/2008US20080318855 Dna encoding for recombinant polypeptide emutants of human stromal cell-derived factor 1
12/25/2008US20080318853 Diagnostic and Therapeutic Use of a Novel Growth Factor, Neublasmin
12/25/2008US20080318852 Epitopes Related to Coeliac Disease
12/25/2008US20080318851 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
12/25/2008US20080318839 Ligand activated transcriptional regulator proteins
12/25/2008US20080318838 Peptides
12/25/2008US20080318835 Novel Integrin Ligand ITGL-TSP
12/25/2008US20080318806 Device for chemical and biochemical reactions using photo-generated reagents
12/25/2008US20080318804 Es Cell Mutation Method and System
12/25/2008US20080318790 Process for the Production of Fine Chemicals
12/25/2008US20080318337 Method for Determining a Tissue Degradation Process by Detection of Comp Neoepitopes
12/25/2008US20080318335 Transgenic Plant for Detecting Environmental Chemicals
12/25/2008US20080318321 Methods for Generating Hypermutable Microbes
12/25/2008US20080318320 Targeting vector to the urokinase plasminogen activator receptor
12/25/2008US20080318319 Novel Method of Nucleic Acid Transfer
12/25/2008US20080318312 Pancreatic islet transcription factor and uses thereof
12/25/2008US20080318311 Encapsulated Bacteriophage Formulation
12/25/2008US20080318298 Uncoupling of DNA insert propagation and expression of protein for phage display
12/25/2008US20080318297 Inhibition of Infiltration, and Cell Killing Agent
12/25/2008US20080318295 capable of reducing or converting the compound I-[4-(4-fluoro2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-propan-2-one to the corresponding product (R) 1-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-propan-2-
12/25/2008US20080318292 Methods of generating protein variants
12/25/2008US20080318290 Novel aldolase and production process of substituted alpha-keto acids
12/25/2008US20080318286 P1-35 Expression Units
12/25/2008US20080318283 Fermentation Process for Continuous Plasmid Dna Production
12/25/2008US20080318278 Ammonia-Specific 5'-Xmp Aminase Mutant
12/25/2008US20080318277 Expression of human milk proteins in transgenic plants
12/25/2008US20080318276 Human Coagulation Factor VII Variants
12/25/2008US20080318275 Hepatitis C virus asialoglycoproteins
12/25/2008US20080318273 Mutant proteinase with reduced self-cleavage activity and method of purification
12/25/2008US20080318272 Gene Encoding Methylated Catechin Synthase
12/25/2008US20080318271 Serine protease for enhancing washing performance of detergents; laundry and dishwashing; isolated from Bacillus strains
12/25/2008US20080318267 Methods and Compositions for Ultra-High Throughput Screening of Natural Products
12/25/2008US20080318251 G protein coupled receptors for use as tools in identifying modulators of taste perception
12/25/2008US20080318239 Compositions and methods for the diagnosis and treatment of tumor
12/25/2008US20080318238 Method of detecting gene mutation
12/25/2008US20080318227 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
12/25/2008US20080318208 Dengue Reporter Virus and Methods of Making and Using the Same
12/25/2008US20080318204 Highly-Sensitive Genomic Assays Employing Chimeric Bacteriophage Standards
12/25/2008US20080317881 Method for sustainable transgene transcription
12/25/2008US20080317880 Plant isoflavone and isoflavanone o-methyltransferase genes
12/25/2008US20080317840 Compositions and methods for polymer-caged liposomes
12/25/2008US20080317839 Amino acid lipids and uses thereof
12/25/2008US20080317811 Treatment of Cancer Using Tlr3 Agonists
12/25/2008US20080317786 Genetically Modified Babesia Parasites Expressing Protective Tick Antigens and Uses Thereof
12/25/2008US20080317779 Hiv Tat-Cd4 Hybrid Molecules and Methods of Use Thereof
12/25/2008US20080317778 Modified vaccinia ankara virus variant and cultivation method
12/25/2008US20080317773 Conjugates that contain the homeodomain of antennapedia
12/25/2008US20080317772 Compounds and methods for treatment and diagnosis of chlamydial infection
12/25/2008US20080317763 Regulation of Metalloprotease Cleavage of Cell Surface Proteins
12/25/2008US20080317762 Bacterial Contact Inhibition and Methods Therefor
12/25/2008US20080317759 Therapeutic uses of factors which inhibit or neutralize MIF activity
12/25/2008US20080317757 Human monoclonal antibody binding to hGM-CSF and its antigen binding portion
12/25/2008US20080317756 Antibodies to Chemokine Alpha-5
12/25/2008US20080317755 Compositions and methods for the therapy and diagnosis of colon cancer
12/25/2008US20080317754 Human Osteoclast Derived Cathepsin
12/25/2008US20080317751 Idiotype Vaccination with Bispecific and Multispecific Immunoglobulin Molecules
12/25/2008US20080317750 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability
12/25/2008US20080317748 Using DCRS5 cytokine receptors modulators to treat psoriasis and atopic dermatitis
12/25/2008US20080317743 Human Artificial Chromosome Containing Human Antibody Lambda Light Chain Gene And Non-Human Animal Containing The Human Artificial Chromosome Capable Of Genetic Transmission
12/25/2008US20080317731 Phospholipases, Nucleic Acids Encoding Them and Methods for Making and Using Them
12/25/2008US20080317723 Lymphatic endothelial cells materials and methods
12/25/2008US20080317722 Methods and Compositions Involving Developmental Decision Promoter Regions
12/25/2008US20080317717 Anti-hepatitis b virus ribozymal nucleic acid
12/25/2008US20080317716 Antigen, nucleic acid that encodes fusion protein; therapy, prevention of tuberculosis infections
12/25/2008US20080317713 Derivatives of growth hormone and related proteins
12/24/2008WO2008157834A1 Materials and methods for diagnosis of asthma